TriHealth Cancer Institute's collaboration with the Tempus AI TIME program impact on clinical trial operations and enrollment

被引：0
|
作者：
Maher, James F.
Mallahan, Samantha
Claes, Jason Joseph
Thompson, Wayne
Kuritzky, Benjamin
Neff, Robert
Shatavi, Seerin Viviane
Rice, Courtney
Huelsman, Karen M.
Budde, Leanne S.
Adhami, Faisal
Shulman, Megan
Degele, Meghan
Donovan, Blathnaid
Skelly, Danielle
Patnaude, Emily
Clifford, Christian
Darmofal, Annie
Osterman, Chelsea Kendall
Cooney, Matthew M.
机构：
[1] TriHlth Canc Inst, Cincinnati, OH USA
[2] Tempus AI, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1553
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute
    Tolaney, Sara M.
    Lydon, Christine A.
    Li, Tianyu
    Dai, Jiale
    Standring, Andrea
    Legor, Kristen A.
    Caparrotta, Caryn M.
    Schenker, Matthew P.
    Glazer, Daniel, I
    Tayob, Nabihah
    DuBois, Steven G.
    Meyerhardt, Jeffrey A.
    Taplin, Mary-Ellen
    Johnson, Bruce E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (11): : 1453 - 1459
  • [42] Case-Linked Analysis of Clinical Trial Enrollment Among Adolescents and Young Adults at a National Cancer Institute-Designated Comprehensive Cancer Center
    Collins, Chelsea L.
    Malvar, Jemily
    Hamilton, Ann S.
    Deapen, Dennis M.
    Freyer, David R.
    CANCER, 2015, 121 (24) : 4398 - 4406
  • [43] Addressing Racial, Ethnic, and Age Disparities in Cancer Clinical Trial Enrollment Time to Stop Tinkering Around the Edges
    Gaddy, Jacquelyne J.
    Gross, Cary P.
    JAMA ONCOLOGY, 2022, 8 (12) : 1792 - 1793
  • [44] North Carolina Central University and Duke Cancer Institute's collaborative cancer research and education program: Connecting cancer disparities translational research, clinical trials operations, and community engagement
    Williams, Kevin P.
    Barrett, Nadine J.
    Oldham, Carla E.
    Hough, Holly
    Woodard, Artis
    Freedman, Jennifer
    Devi, Gayathri R.
    Patierno, Steven R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [45] Why providers participate in clinical trials: Considering the National Cancer Institute's Community Clinical Oncology Program
    McAlearney, Ann Scheck
    Song, Paula H.
    Reiter, Kristin L.
    CONTEMPORARY CLINICAL TRIALS, 2012, 33 (06) : 1143 - 1149
  • [46] Evaluating a National Dissemination Approach: The National Cancer Institute's Clinical Trials Education Program
    Solomon, Felicia M.
    Thakkar, Sona
    Zambon, Allison
    Eckstein, Daniel S.
    Michaels, Margo
    Johnson, Lenora
    Squiers, Linda
    JOURNAL OF CANCER EDUCATION, 2009, 24 (01) : 49 - 57
  • [47] Evaluating a national dissemination approach: The National Cancer Institute’s clinical trials education program
    Felicia M. Solomon
    Sona Thakkar
    Allison Zambon
    Daniel S. Eckstein
    Margo Michaels
    Lenora Johnson
    Linda Squiers
    Journal of Cancer Education, 2009, 24 : 49 - 57
  • [48] CLINICAL TRIAL ENROLLMENT RATE AMONG ADOLESCENT AND YOUNG ADULTS WITH CENTRAL NERVOUS SYSTEM TUMOR AT DANA-FARBER CANCER INSTITUTE (DFCI)
    Sarvode, Supriya
    Warren, Katherine
    Reardon, David
    Yeo, Kee Kiat
    NEURO-ONCOLOGY, 2020, 22 : 86 - 86
  • [49] Clinical Trial Enrollment Among Adolescent and Young Adults with Primary Central Nervous System Tumors Treated at the Dana-Farber Cancer Institute
    Sarvode, Supriya
    Vogelzang, Jayne R.
    Sarvode Mothi, Suraj
    Warren, Katherine E.
    Reardon, David A.
    Yeo, Kee Kiat
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2022, 11 (06) : 543 - 549
  • [50] Do clinical trial infrastructures impact enrollment rates and baseline demographics in early Parkinson's disease (PD) studies?
    Kamp, C
    Shinaman, A
    Kieburtz, K
    Ravina, B
    Tilley, B
    Brocht, A
    Shannon, K
    Tanner, CM
    Wooten, FG
    Yuko, P
    Jordan, E
    MOVEMENT DISORDERS, 2004, 19 : S198 - S198
12345